Parmax Pharma Ltd share price logo

Parmax Pharma Ltd Share Price (540359)

₹36.791.02%

as on

| Source : BSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Parmax Pharma Ltd Stock Performance

as on August 22, 2025 at 4:01 PM IST

  • Day's Low

    Day's High

    ₹34.5
    ₹36.8
    downward going graph

    6.22%

    Downside

    0.03%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    ₹31.5
    ₹55.02
    downward going graph

    14.38%

    Downside

    49.55%

    Upside

    downward going graph
Previous Close₹36.42
Open₹35.48
Volume504.00
Upper Circuit₹43.70
Lower Circuit₹29.14
Day's Low34.5
Day's High36.8
52 Week Low31.5
52 Week High55.02
1 Month Return-6.84 %
3 Month Return-17.05 %
1 Year Return+ 8.21 %
3 Year Return+ 9.82 %
5 Year Return-10.38 %

Parmax Pharma Ltd Stock Fundamentals & Key Indicators

Check Parmax Pharma Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

₹13.76 Cr

Return on Equity (ROE)

0

PE Ratio (TTM)

0

Return on capital employed (ROCE)

0

Beta (LTM)

-0.19

P/B Ratio

178

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

-7700

EPS (TTM)

0

Sector

Pharmaceuticals

Book Value

0

Technical Analysis

Parmax Pharma Ltd Stock's Interest Amongst Investors

44%

Period Aug 24, 2025 to Jul 25, 2025. Change in 30 Days vs previous period

Search interest for Parmax Pharma Ltd Stock has increased by 44% in the last 30 days, reflecting an upward trend in search activity.

Parmax Pharma Ltd Financial Results

Get the annual and quarterly financial summary of Parmax Pharma Ltd, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26
Revenue

(in ₹ Cr)

8 (0%)9 (19%)6 (32%)5 (23%)2 (60%)
Net Income

(in ₹ Cr)

0 (0%)-0 (2300%)-0 (77%)-1 (282%)-1 (49%)
Net Profit Margin0.13% (0%)-2.37% (1923%)-6.21% (162%)-30.85% (397%)-39.18% (27%)
Value in ₹ crore
DetailsFY21FY22FY23FY24
Total Assets

(in ₹ Cr)

23 (0%)18 (21%)18 (2%)15 (13%)
Total Liabilities

(in ₹ Cr)

17 (0%)12 (29%)12 (2%)15 (30%)
Value in ₹ crore
DetailsFY20FY21FY22FY23FY24
Operating Cash Flow

(in ₹ Cr)

3 (0%)4 (25%)1 (79%)0 (56%)-0 (158%)

Parmax Pharma Ltd Earnings and Dividends

View detailed summary of the earnings and dividend history of Parmax Pharma Ltd.

  • Parmax Pharma Ltd Earnings Results

    Parmax Pharma Ltd’s net profit fell -7700% since last year same period to ₹0.76Cr in the Q1 2025-2026. On a quarterly growth basis, Parmax Pharma Ltd has generated 48.99% jump in its net profits since last 3-months.

    Read More about Earnings Results

Parmax Pharma Ltd Stock Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Parmax Pharma Ltd.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
30.8%
0.00
Foreign Institutions
0%
0.00
Mutual Funds
0%
0.00
Retail Investors
69.2%
0.00
Others
0%
0.00

Parmax Pharma Ltd vs Peers

Compare market cap, revenue, PE, and other key metrics of Parmax Pharma Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
NA13.76-2.08%0.00-611
NA355.90-5.99%0.6951,684
NA140.6316.77%0.847339
NA979.15294.15%0.7471
NA594.46136.72%0.85-1107

Insights on Parmax Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 26.7% return, outperforming this stock by 18.5%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 30.80% of holdings in Jun 2025 quarter

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 69.20% of holdings in Jun 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 140.4% return, outperforming this stock by 130.5%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, Parmax Pharma stock has moved down by -17.1%

About Parmax Pharma Ltd

Parmax Pharma PPL is a public limited company which was incorporated in November 1994 and promoted by Jayantilal S Dhol Purushottam J Bhalodi and Prabhudas D Hansalpara. It has set up a plant in Hadamtala Gujarat and has an installed capacity of 96 tonnes per annum for the production of bulk drugs such as amoxycillin trihydrate, ampicillin trihydrate, cephalexin mono hydrate and nalidixic acid. Its Antibiotic project has been completely implemented since 31st May 1997 and its non Antibiotic products project is currently in its final stages of implementation.

Revenue: ₹1.94Cr as on June 2025 (Q1 FY26)
Net Profit: ₹0.76Cr as on June 2025 (Q1 FY26)
OrganisationParmax Pharma Ltd
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs

What is Parmax Pharma Ltd share price today?

Parmax Pharma Ltd share price today stands at ₹36.79, Open: ₹35.48, Previous Close: ₹36.42, High: ₹36.8, Low: ₹34.5, 52 Week High: ₹55.02, 52 Week Low: ₹31.5 as on .

How to buy Parmax Pharma Ltd shares ?

To buy Parmax Pharma Ltd shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for 540359 or Parmax Pharma Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Parmax Pharma Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is today's traded volume of Parmax Pharma Ltd?

Today's traded volume of Parmax Pharma Ltd is 504.00. Which means that 504.00 shares of Parmax Pharma Ltd were bought and sold on the stock market during today's trading session.

What is Parmax Pharma Ltd's market cap today?

Today's market capitalisation of Parmax Pharma Ltd is ₹13.76 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.

What is the 52 week high and 52 week low range of Parmax Pharma Ltd?

Parmax Pharma Ltd’s 52 week high is ₹55.02 and 52 week low is ₹31.5. The current share price of Parmax Pharma Ltd is ₹36.79, which is -33.13% down from its 52 week high and 16.79% up from its 52 week low.